Toshiharu Komori

Ash1l Methylates Lys36 of Histone H3 Independently of Transcriptional Elongation to Counteract Polycomb Silencing

Hitomi Miyazaki, Ken Higashimoto, Yukari Yada et al. · PLoS Genetics · 2013 · 86 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> Mutations

Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi et al. · Molecular Cancer Research · 2019 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use

Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa et al. · ACS Medicinal Chemistry Letters · 2023 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

Role of human transcription elongation factor DSIF in the suppression of senescence and apoptosis

Toshiharu Komori, Naoto Inukai, Tomoko Yamada et al. · Genes to Cells · 2009 · 26 citations

Life Sciences, Genetics, Molecular Biology +14

Schlafen11 Expression Is Associated With the Antitumor Activity of Trabectedin in Human Sarcoma Cell Lines

Junya Iwasaki, Toshiharu Komori, Fumio Nakagawa et al. · Anticancer Research · 2019 · 23 citations · Full text

Medicine, Oncology, Pharmacology +15